GOODLIFE PHARMA

Active

Public limited companyfounded 2012active for 14 yearsRue François-Massart 27, 1450 Chastre, BelgiumKBO/BCE: BE 0845.590.372

Summary

GOODLIFE PHARMA has been active since 2012 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €769,473 and a net result of €119,670. Equity is growing by about 74% per year across the filed financial years. Its solvency ranks better than 20% of 6,142 sector peers (NACE 46, financial year 2025). The computed 12-month bankruptcy probability is 0.2% (very low).

Risk analysisFollow Report Compare

GOODLIFE PHARMAActiveChecked score 90/100

Risk analysis Report Compare

Activity

Wholesale of pharmaceutical and medical goods

NACE 46460

Largest company by total assets in Chastre, Wholesale and retail trade sector1 site

Size

€4.3mtotal assets 2025

Staff: 3.3 FTE
Equity: €769,473
Profit: €119,670

Financial health

90 Excellent Checked score 2025

Bankruptcy probabilitywithin 12 months: 0.2%

Structure

Board: 6 members

Sterq Management SRLManaging director · permanent representative Koen Perenboom

2025 accounts filed 61 days late3 of 8 deeds summarised

Why 90raises riskLast filed accounts filed 61 days late; 1 of the last 3 latelowers riskSize: 3.3 FTE, total assets €4.3mFigures for financial year 2025 (filed 07-10-2026)Founded in 2012Show the evidence

Checked score

Score 2025

90 / 100

Excellent

Probability in this band: under 0.55%

Financially better than 47% of its sector peers (NACE 46, micro)

Every signal that counts is listed under Signals.

Financial strength · tick = 2024

Average

Solvency 43+5

equity 17.9% of total assets

Liquidity 43+23

short-term debt 30.8% · cash 5.0%

Profitability 59-16

return on assets 2.8%

Bankruptcy probability, 12 months

0.2% Very low

0%0.5%1.5%4%10%≥ 25%

About 2 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median 0.4% (26,881 companies, NACE 46, micro)

Last 24 months 11-2024: 0.2% 12-2024: 0.2%● unchanged vs 11-2024 01-2025: 0.2%● unchanged vs 12-2024 02-2025: 0.2%● unchanged vs 01-2025 03-2025: 0.2%● unchanged vs 02-2025 04-2025: 0.2%● unchanged vs 03-2025 05-2025: 0.2%● unchanged vs 04-2025 06-2025: 0.4%▲ +0.2 percentage points vs 05-2025 07-2025: 0.5%▲ +0.1 percentage points vs 06-2025 08-2025: 0.4%▼ -0.1 percentage points vs 07-2025 09-2025: 0.4%● unchanged vs 08-2025 10-2025: 0.4%● unchanged vs 09-2025 11-2025: 0.4%● unchanged vs 10-2025 12-2025: 0.4%● unchanged vs 11-2025 01-2026: 0.4%● unchanged vs 12-2025 02-2026: 0.4%● unchanged vs 01-2026 03-2026: 0.4%● unchanged vs 02-2026 04-2026: 0.5%▲ +0.1 percentage points vs 03-2026 05-2026: 0.5%● unchanged vs 04-2026 06-2026: 0.6%▲ +0.1 percentage points vs 05-2026 07-2026: 0.6%● unchanged vs 06-2026 08-2026: 1.2%▲ +0.6 percentage points vs 07-2026 09-2026: 1.5%▲ +0.3 percentage points vs 08-2026highest value 10-2026: 0.2%▼ -1.3 percentage points vs 09-2026lowest value

Credit of up to €65,000 on 30-day terms is acceptable

Liquidity ample (current ratio 3.16, compared with 1.63 in 2024, above the usual 1.5; short-term debt: 30.8% and cash: 5% of total assets), but 82.1% of the assets are financed with debt and provisions.

How it is calculated

The band follows from the bankruptcy probability, on a scale where 10 more points roughly halve it:

75-100	Excellent	under 0.55%
60-74	Healthy	0.55% to 1.5%
45-59	Fair	1.5% to 4.2%
25-44	Weak	4.2% to 15.0%
0-24	Critical	over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 46, micro): better than 30% on solvency, 41% on liquidity, 44% on profitability and 74% on growth.

The bankruptcy probability was computed on 27-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. Negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late hold it at Fair at most (59); two missing filings, at Weak (44). An ongoing judicial reorganisation or the company's end (bankruptcy, dissolution, liquidation) holds it at Critical at most (24).

Credit check for your own amount and term

Show the recommended maximum and see how the verdict changes with amount, term and advance.

Signals

Six signals.

lowers riskraises risk

Size: 3.3 FTE, total assets €4.3m

Companies of this size fail less often; how much that weighs depends on the rest of its profile.

NBB · annual accounts

Figures for financial year 2025 (filed 07-10-2026)

NBB · annual accounts

Last filed accounts filed 61 days late; 1 of the last 3 late

NBB · filings

Founded in 2012

Companies that have existed this long fail less often; how much that weighs depends on the rest of its profile.

KBO

Weak solvency vs sector

Solvency (equity / total assets) is in the sector's weakest quartile: better than 20% of 6142 sector peers (2025).

NBB · sector comparison

Position among 6142 sector peers

Solvency

better than 20%

← weakest strongest →

2025 accounts filed 61 days late

The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 30-09-2026, 61 days later. Nearly half (47%) of Belgian companies file late; of those that file 1 to 90 days late, 2.0% are now bankrupt, dissolved or in another special legal status, against 1.66% of all filers. A delay like this does not count in the score.

NBB · 10 filings

Deviation from the deadline

2025

61 days late

2024

2 days early

2023

19 days late

2022

3 days early

2021

8 days early

2020

2 days early

2019

2 days early

← before the deadline after the deadline →

tick = median of all Belgian filingsring = median in the sector

This company filed its last 7 accounts on average 9 days after the deadline; the sector median (NACE 46) for financial year 2024 is 3 days before the deadline, and 39% of those companies filed late.

Searched, nothing found (2)

Next filing not due yet

The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 29 July (4 of the last 5 filed years within 30 days of that day).

Companies Code · seven months

Where today falls in the filing period

28-10-2026 today31-12-2026 year end31-07-2027 deadline

No strike-offs in the KBO publications

Searched since 2021.

KBO publications · our coverage

30-09-2026 Annual accounts filedfinancial year 2025 · full…
09-06-2026 Resignation: Nathalie Schewebach (director)Appointments: Belvita Healthcare SRL (director)…
29-07-2025 Annual accounts filedfinancial year 2024 · full…

Key points

Positive: Largest company by total assets in Chastre, Wholesale and retail trade sectorin the Checked rankings No. 1 View
Caution: Result fell in 2025from €259,803 to €119,670 ▼ 53.9% View
Board changedlatest change 02-03-2026 · 6 in office 3 joined · 1 left View
Caution: Latest accounts filed lateafter the legal deadline 61 days View
Positive: 6 profitable years in a rowprofit 2025: €119,670 6 years View

By topic

Financials

Financial year: 2025
Total assets: €4.3m
Profit: €119,670
Solvency: 17.9%

Total assets▼ 15.9%

Net result

20182025

Go to Financials

Board & ownership

Board: 6 members

Schewebach, NathalleDirector
Sterq Management B.V.Director
Belvita Healthcare SRLDirector
SCHEWEBACHDirector
LMW ManagementManaging director

and 1 other director

Go to Board & ownership

Timeline

Events: 23
Since: 2014
Next accounts: by 31-07-2027

10-01-2025Resignation: LMW Management SRL (director and managing…
31-12-2024Equity above €500,000
19-08-2024Annual accounts filed

Go to Timeline

Company details

Sites: 1

Legal form: Public limited company
Activity: Wholesale of pharmaceutical and medical goodsNACE 46460
Founded: 11-04-2012
Year ends: 31-12
Peppol: Reachable for e-invoices

Go to Company details

Articles of association

Provisions read: 25

Annual meeting: Last Friday of June at 19:00
Purpose: “Le commerce sous toutes ses formes (achat et vente) ainsi que la production et la…” (deed in French)

Go to Articles of association

Key facts about GOODLIFE PHARMA

What is the company number of GOODLIFE PHARMA?: 0845.590.372. In Belgium the VAT number is the company number with BE in front: BE 0845.590.372.
Where is GOODLIFE PHARMA based?: The registered office is at Rue François-Massart 27, 1450 Chastre.Company details
What does GOODLIFE PHARMA do?: According to the KBO register, the main activity is wholesale of pharmaceutical and medical goods (NACE 46460).
What is the legal form of GOODLIFE PHARMA?: Public limited company (NV).
When was GOODLIFE PHARMA founded?: On 11-04-2012.
Is GOODLIFE PHARMA still active?: Yes, GOODLIFE PHARMA is an active enterprise in the KBO register.
How many employees does GOODLIFE PHARMA have?: On average 3.3 full-time equivalents in financial year 2025, according to the filed annual accounts.Financials
What is the turnover of GOODLIFE PHARMA?: Not stated in the processed annual accounts. The abridged format for small companies does not require turnover.
Is GOODLIFE PHARMA profitable?: In financial year 2025, GOODLIFE PHARMA made a profit of €119,670.
Where can I find the annual accounts of GOODLIFE PHARMA?: GOODLIFE PHARMA filed 13 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of GOODLIFE PHARMA due?: By 31-07-2027, for financial year 2026.Timeline